Wednesday, 13 Dec 2017

PsA/SpA

Datesort ascending Type Title Save
05 Nov 2017 Social RT @_connectedcare: Another study discussing progression to AS. Slightly inflammatory last comment #ACR17 @rheumnow https://t.co/UMVZf1rKET
05 Nov 2017 Social RT @japaoli19: UST tops TNFi resolving enthesitis in a small sample of PsA pts. ECLIPSA #881 #ACR17 @RheumNow https://t.co/5AKRP473dD https…
05 Nov 2017 Social RT @DrPetryna: 53% risk of VTE and 62%DVT in AS comparing to general population. Confounders not measured #ACR17 #3S078 @RheumNow https://t…
05 Nov 2017 Social RT @japaoli19: Higher risk of VTE on patients hospitalized with SpA, comparable with that of malignancy>OA #879 #ACR2017 @RheumNow https://…
05 Nov 2017 Social RT @doctorakerkar: >90% PsA patients showed no radiologic progression at 12 months on Tofacitinib Desiree Van Der Heijde #880 #ACR17 @Rheu…
05 Nov 2017 Social RT @doctorakerkar: Higher prevalence of venous thrombosis in SpA admissions- Inflammation driven thrombosis & NSAIDs to blame? Dilli Poude…
05 Nov 2017 Social RT @japaoli19: #578 Of 10 Biomarkers, combo of 2 showed small value added in terms of rad.progression in AxSpA #ACR17 @RheumNow
05 Nov 2017 Social RT @japaoli19: Low dose CT detects more spinal progression vs xray in AS measured by ct syndesmophyte sc #582 #ACR17 @rheumnow https://t.…
05 Nov 2017 Social RT @KDAO2011: #ACR17 metaanalysis:Adding MTX to TNFi helps skin scores NOT joints in pts w/PsA @rheumnow #636 https://t.co/2vAQgnYZXp
05 Nov 2017 Social Mease et al shows consentyx inhibits xray progression in Future5 996 PsA trial w 24wk outcomes https://t.co/qJqMZMulhP
05 Nov 2017 News Novartis Features Secukinumab Data at ACR 17
04 Nov 2017 Social RT @isa75012: Secukinumab (IL17i) works even in SpA pts that do not respond to TnFi. But it also may cause worsening IBD symptoms. Use caut…
04 Nov 2017 Social RT @DrPetryna: GI mucosal associated invariant T (MAIT) cells detected in joints of patients w/AS. Expanding views of SpA #ACR17 Sunday pre…
04 Nov 2017 Social RT @drdavidliew: Biologics in SpA - it’s a minefield out there! #ACR17 https://t.co/zR49ms7rF1
04 Nov 2017 Social RT @cgytz: Lumbar mobility is impaired first in SpA. Screen with modified Schober and lateral spinal flexion. #rheumedu #ACR17 https://t.co…
04 Nov 2017 Social RT @psufka: Although I enjoy reading them, plain X-rays of SI joints unreliable for spondyloarthropathy. MRI is much much better. #ACR17 @r…
04 Nov 2017 Social RT @DrBhana: EULAR 2017 TtT recommendations for SpA #ACR17 https://t.co/jMgo29PGQf
04 Nov 2017 Social RT @DrBhana: ACR 2016 treatment guidelines for AS/SpA #ACR17 https://t.co/c1kKEMtgKV
04 Nov 2017 Social RT @_connectedcare: Higher disease activity leads to more progression in axial spondyloarthritis #ACR17 https://t.co/wD3FhU0CD4
04 Nov 2017 Social RT @cgytz: Osteitis condensans ilii can mimic AxSpA including inflammatory back pain #ACR17 https://t.co/vi9QodEBmM